XORTX Therapeutics Inc Stock
Price
Target price
€0.29
€0.29
-2.680%
-0.0085
-2.680%
-
09.11.23 / Tradegate
WKN: A3C9TS / Name: XORTX / Stock / Metals & Mining / Micro Cap /
We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock XORTX Therapeutics Inc is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for XORTX
sharewise wants to provide you with the best news and tools for XORTX, so we directly link to the best financial data sources.
Financials
News
XORTX Clarifies Timing for Share Consolidation
CALGARY, AB – November 10, 2023 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on
XORTX Announces Share Consolidation
CALGARY, AB - November 8, 2023 - XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023
- Preclinical Findings Help Clarify and Reinforce the Role of Uric Acid in the Pathogenesis of Polycystic Kidney Disease and the Potential of XORTX’s Proprietary Formulation of